Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina

被引:69
作者
Lee, Juneyoung [1 ]
Choi, Yunjung [1 ]
Woo, Eun-Rhan [2 ]
Lee, Dong Gun [1 ]
机构
[1] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, Taegu 702701, South Korea
[2] Chosun Univ, Coll Pharm, Kwangju 501759, South Korea
关键词
Isocryptomerin; Biflavonoid; Antifungal activity; Membrane-disruption mechanism(s); CANDIDA-ALBICANS; MEDICINAL-PLANTS; ANTIMICROBIAL PEPTIDES; PHOSPHOLIPASE A(2); AMPHOTERICIN-B; IN-VITRO; EXPRESSION; SUSCEPTIBILITY; BIFLAVONOIDS; SUPPRESSION;
D O I
10.1016/j.bbrc.2008.12.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Isocryptomerin is a biflavonoid isolated from Selaginella tamariscina used in traditional medicine. In this study, we investigated novel antifungal properties of isocryptomerin. The results indicated that isocryptomerin exerted antifungal activity in an energy-independent manner without remarkable hemolytic effects. To understand mode of action(s) of isocryptomerin, we conducted experiments on Candida albicans, a noted human pathogenic fungal strain. Flow cytometric analysis with bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC(4)(3)], a translational membrane potential dye, regeneration test with fungal protoplasts, and fluorescence analysis with 1,6-diphenyl-1,3,5-hexatriene (DPH), a probe for membrane studies by depolarization, indicated that isocryptomerin could depolarize fungal plasma membrane. In conclusion, the results suggested that the antifungal activities of isocryptomerin might be due to its membrane-disruption mechanism(s). (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:676 / 680
页数:5
相关论文
共 35 条
[1]
INHIBITION OF MAST-CELL HISTAMINE-RELEASE BY FLAVONOIDS AND BIFLAVONOIDS [J].
AMELLAL, M ;
BRONNER, C ;
BRIANCON, F ;
HAAG, M ;
ANTON, R ;
LANDRY, Y .
PLANTA MEDICA, 1985, 51 (01) :16-20
[2]
Inhibition of TNFα-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-κB activation in A549 cells [J].
Banerjee, T ;
Valacchi, G ;
Ziboh, VA ;
van der Vliet, A .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2002, 238 (1-2) :105-110
[3]
KINETICS OF THE INHIBITORY EFFECT OF FLAVONOIDS ON HISTAMINE-SECRETION FROM MAST-CELLS [J].
BRONNER, C ;
LANDRY, Y .
AGENTS AND ACTIONS, 1985, 16 (3-4) :147-151
[4]
Synthesis of phospholipase A2 inhibitory biflavonoids [J].
Chen, JJ ;
Chang, HW ;
Kim, HP ;
Park, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2373-2375
[5]
NEW CONTRIBUTION TO THE ETHNOPHARMACOLOGICAL STUDY OF THE CANARY ISLANDS [J].
DARIAS, V ;
BRAVO, L ;
RABANAL, R ;
MATEO, CS ;
LUIS, RMG ;
PEREZ, AMH .
JOURNAL OF ETHNOPHARMACOLOGY, 1989, 25 (01) :77-92
[6]
EFFECT OF CARBONYL CYANIDE META-CHLOROPHENYLHYDRAZONE ON ESCHERICHIA-COLI HALOTOLERANCE [J].
GHOUL, M ;
POMMEPUY, M ;
MOILLOBATT, A ;
CORMIER, M .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1989, 55 (04) :1040-1043
[7]
Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A(2) with anti-inflammatory activity [J].
Gil, B ;
Sanz, MJ ;
Terencio, MC ;
Gunasegaran, R ;
Paya, M ;
Alcaraz, MJ .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (05) :733-740
[8]
Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008
[9]
Amphotericin B: New life for an old drug [J].
Hartsel, S ;
Bolard, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (12) :445-449
[10]
Novel triazole antifungal agents [J].
Hoffman, HL ;
Ernst, EJ ;
Klepser, ME .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (03) :593-605